Products
Community
Markets
News
Brokers
More

Markets
Stocks
CRBP
Ideas

Corbus Pharmaceuticals

No trades

See on Supercharts

Overview News

Ideas

Discussions Seasonals

CRBP trade ideas

CRBP $40 TARGET HIT, IS THE 1.618 $60 EXTENSION NEXT?In this update, we delve into the latest developments with Corbus Pharmaceuticals (CRBP), examining whether the recent hit of our $40 target will lead to a correction to $32-$33 or propel the stock directly towards the $50s. With the 1.618 extension potentially setting a target at $59, we analyze the possibilities and implications for traders and investors.

by candlestickninja

CRBP $40 Target post breakout on track CRBP Correction to the .618 level followed by a sideways triangle breakout that was very easy to see is heading towards my $40 target, based on the retracement our extension should actually get into the GETTEX:50S or $60s but my first conservative swing trade target is $40 psych.

Long

by candlestickninja

CRBP On its way to $33 then $40 CRBP On its way to $33 then $40 - I've shown two of my anticipated trajectories depending on whether $29-$20.50 is broken or not, I think we break that by Friday and see $33 psych by Friday, but $39.80 to $40 psych may take a few weeks, this is an ideal swing trade!

Long

by candlestickninja

CRBP on track for $32 then $40 CRBP on track for $32 then $40 - We have been stalled at $28 but when that breaks $32-$33 should come quickly, followed by $40 prior high zone once that breaks (within a month is my forecast)

Long

by candlestickninja

CRBP on it's way to my $40 target, $32 is next though...In today's analysis on TradingView, we're diving into the latest developments in the market. Join us as we examine key trends, potential breakout points, and short-term targets. Stay informed and make data-driven decisions for your trades. (Date: 2/21/2024)

Long

by candlestickninja

Bullish diamond breakout CRBP Get ready for a break towards $40 then eventually $60

Long

by candlestickninja

Short term is bearish to sideways then bullish Week Ahead Glance on Corbus Pharmaceuticals (Ticker: CRBP) as of February 4th, 2024, by Candlestick Ninja! 🌟 Discover the latest insights into CRBP's recent explosive breakout to $40, forming a bullish head and shoulders pattern. We'll explore how it temporarily weakened under $27.50 and why a break of $27.50, eventually $29, could propel us to $35 swiftly. I

Long

by candlestickninja

Soars and Settles, what's next?🚀 Corbus Pharmaceuticals (Ticker: CRBP) made headlines on January 26th, 2024, as its shares skyrocketed an astonishing 207% following the groundbreaking Phase 1 Cancer Study results for patients with nectin-4 positive tumors. 🌟 In this video, we delve into the incredible journey of CRBP stock, breaking down the technical analysis that fueled its meteoric rise. The stock hit a psychological resistance level just below $40 before retracing to the .618 Fibonacci level around $18 and finding support. Currently settling around the $24-$25 .382 Fibonacci retracement level, CRBP appears poised for further gains. 📈 We explore the key levels to watch, with a critical focus on the $29 breakout point, which could propel the stock to $35 and potentially even $40. A breach of the $40 resistance level might pave the way for an exciting journey into the $60 to $80 range. Whether you're a seasoned trader or a curious investor, this video provides valuable insights into CRBP's recent surge and potential future movements. Don't miss out on understanding the technical factors influencing the stock's trajectory and the possible scenarios that could unfold in the coming weeks.

Long

by candlestickninja

bullish piercing candle possibility today!CRBP retraced after it's 3x rise on positive cancer tests/trials. Settling out at the .382 Fibonacci retracement in a healthy triangle formation, with a bullish piercing candle formation underway we are primed for a rip towards $40+

Long

by candlestickninja

Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Holdings, Inc(#CRBP) in good demand area Orange Zone is a place to enter but Considering SL:6.02 Long Term Target:71 means 800% MidTerm Target:20 Measn 150%

Long

by crystorex

BUY CRBP Long position started here looking for a significant gain in a short time frame!

Long

by KML6

CRBP Weekly Analysis Hello Traders! The probability of what I analyzing, is to be true unless the opposite is proven According to my analysis, this is my opinion about weekly chart for CORBUS PHARMACEUTICALS HOLDINGS (CRBP) Feel free dear trader to share with me your opinion, and also your analysis & Keep Watching

Long

by UnknownUnicorn36865916

#CRBP Possible Targets : $2.60 - 3.90 - 7.86 - 9.90 Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded in April 2009 and is headquartered in Norwood, MA. Targets : $2.60 - 3.90 - 7.86 - 9.90 **Disclaimer - not financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams. I would appreciate your feedback on my analysis. Do not view this idea as a recommendation for trading or investing.

Long

by KAPRUKA

Long at 1.2? Trend Breakout Possibly Not financial advice, just an idea. char char char

Long

by talentedd

Possible insane outbreak on CRPB Stock i would long around 1.15, not financial advice of course. let's see how this plays out.

by talentedd

CRBP gamble Stop loss can be so tight that it's probably not the worst gamble out there. Bullish divergence and trying to double bottom around earnings. It rallied on earnings in May so who knows. Very high risk, the company has weak fundamentals.

Long

by Ravich000

Updated

We f*ckt, Don't expect something big in the near future.Always the same with this "penny stocks". I am just going to HODL till $3, after that sell...( not advise what you should do, use your own brain)

by Alexander_papito

CRBP potential golden cross Fundamentals have been rough as of lately for CRBP. phase 3 reaching a critical pivot point for their most recent potential product. this aside, technically speaking we are gathering a cluster of moving averages with the captain 200 day MA getting ready to cross the 9,20,50. Im semi bullish because of its current consolidation its forming on the daily chart, going to need to see price break out of white downward trend line then through the somewhat potential megaphone pattern seen with bottom support line. Not financial advice: do your dd!

by brokerbob

Updated

CRBP phase 3 and phase 2 data coming No investment advice! I do this only for practicing. Most info on the Chart June 2-5 there are coming Data of their Lenabasum We might see a continoung pre run up before the data will be released. Cannabis related stock, as the cannabis sector is heating up. Depending on the Data wie might see a big upside breakout, or back sub 1.

Long

by meitshels_smell_trades

Updated

CRBP double or triple jump very very soon! Been watching this stock for a bit. It finally is about to cross 200MA a strong indicator that it will pop soon and it's jumping (crossed above $2.5 about two days ago and touching $2 now. Put your bets in....timing is everything and it's starting to get hot!

Long

by antonini2002

Target $3 Load here, target $3 - If this fails we will see 1.77 and it won't look very good.

Long

by duhast

Chaos Theory and Fractals: A forgotten name in Healthcare About the Tickers: Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP is a clinical-stage company focused on the development and commercialization of novel medicines designed to target the endocannabinoid system. The Company’s lead product candidate, lenabasum, is a novel, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to provide an alternative to immunosuppressive medications in the treatment of chronic inflammatory and fibrotic diseases. Lenabasum is currently being evaluated in dermatomyositis and systemic lupus erythematosus. Corbus is also developing a pipeline of other preclinical drug candidates from its endocannabinoid system platform. Phase 3 trial of Lenabasum in Systemic Sclerosis was unsuccessful last year. Currently, a phase 3 trial in Dermatomyositis is scheduled to read out top line results by Q2 2021. The Chart: Appears similar to Cassava NASDAQ:SAVA which also saw setbacks and plunged to about $1 a share. Can we use fractals and chaos theory to predict the price of $CRBP stock in the near term? Possibly. Corbus Pharmaceuticals ($CRBP) is currently trading at about $2 a share. Cassava Sciences ($SAVA) is trading at about $54 a share.

by FVCapitalManagement

CRBP will explode soon After all this time hodl, CRBP is going to reward us with a 200%. the big triangle should explode upwards. to then enter an up trend. the little triangle is a messenger of the explosion. just like a silence before the storm. let's see what's going to happen

Long

by Alexander_papito

Love in every #TradingView

90M+

Traders and investors use our platform.

Top website in the world when it comes to all things investing.

1.5M+

Mobile reviews with 4.9 average rating. No other fintech apps are more loved.

10M+

Custom scripts and ideas shared by our users.

@johndollery

@horibuful

@fx.today

@TradingView

@monolith_trading

@akamenyar

@youngtraderwealth

@Trading_Jazz

@half_bake_chef

@trade_surfer

@Trader1Andy

@tradingirls

@tradewithaks

@tanhef

@tradinglifestylestore

@ice.sef

@tradeonwheels

@felix_hartmann

Whatever the trade

Here's why Here's why

Products

Supercharts
Pine Script™
Stock Screener
ETF Screener
Forex Screener
Crypto Coins Screener
Crypto Pairs Screener
DEX Pairs Screener
Stock Heatmap
ETF Heatmap
Crypto Heatmap
Economic Calendar
Earnings Calendar
Sparks
News
TradingView Desktop
Mobile app
CME Group futures
Eurex futures
US stocks bundle

Company

About
Features
Pricing
Social network
Wall of Love
Athletes
Manifesto
Careers
Blog
Security vulnerability
Status page
Terms of use
Disclaimer
Privacy policy
Cookies policy
Media kit
Accessibility statement
Tarot cards for traders

Community

Refer a friend
Ideas
Scripts
House rules
Moderators
Pine Script™ Wizards
Chat

For business

Widgets
Advertising
Charting libraries
Lightweight Charts™
Advanced Charts
Trading Platform
Brokerage integration
Partner program
Education program